Table 1

Patient characteristics

Case

Sex/Age

Location

Pathology & Grade

GADD45b positivity (%)


1

♂/43

Femur

Enchondroma

68.9

2

♂/16

Metatarsal

Enchondroma

81.6

3

♀/46

Phalanx

Enchondroma

74.4

4

♂/32

Phalanx

Enchondroma

83.5

5

♀/58

Femur

Enchondroma

66.6

6

♀/54

Phalanx

Enchondroma

68.8

7

♀/52

Femur

CSA grade I

67.3

8

♂/39

Pelvis

CSA grade I

55.5

9

♀/46

Femur

CSA grade I

44.6

10

♂/61

Femur

CSA grade I

49.2

11

♂/18

Tibia

CSA grade I

29.8

12

♂/67

Mandible

CSA grade I

38.1

13

♀/32

Pelvis

CSA grade I

31.0

14

♀/50

Femur

CSA grade II

11.8

15

♀/64

Rib

CSA grade II

3.9

16

♀/72

Femur

CSA grade II

14.8

17

♀/55

Pelvis

CSA grade II

5.9

18

♂/44

Femur

CSA grade II

11.9

19

♂/67

Mandible

CSA grade II

34.0

20

♂/61

Mandible

CSA grade III

3.8


Zenmyo et al. Diagnostic Pathology 2010 5:69   doi:10.1186/1746-1596-5-69

Open Data